(Reuters) – Capricor Therapeutics Inc said on Wednesday it had put on hold a clinical trial of its drug to treat Duchenne muscular dystrophy (DMD), a muscle-wasting disorder, citing a safety review. The review follows a severe allergic reaction during infusion of the drug, the company said in a filing here. The patient responded well… Read More »
December 5, 2018 Posted By Categories Gary Schwitzer is the Founder & Publisher of HealthNewsReview.org. He tweets as @garyschwitzer. Australian researchers at the University of Queensland reported that “a quick and easy test to detect cancer from blood or biopsy tissue could eventually result in a new approach to patient diagnosis.” A news release quoted one… Read More »
In 2012, a group of entrepreneurs and academics in Cambridge, Massachusetts, hatched a plan to solve one of the holy grails in health tech.